The effect of activated CD28WTCD8+ T cells and CD28KOCD8+ T cells on the tumor-killing ability of CD8+ Teff cells was further tested in B16.gp33 melanoma-bearing C57BL/6 (B6) mice. This evidence concerns the gene CD8A and neoplasm.